>M9TVQ7 Carnitine O-palmitoyltransferase II (EC 2.3.1.21)
MPLPTLEASCERFLAWCAPLLTAEERAATEAEVTAFLRPGGTGRILHAALEEYDATDGVH
SWLDTFWPYRYLGRRDRIALNANFFFLFKDTGEGQLDRAAGLVAGALHYKRQLDEGLIAP
VEQRGVPQSMVQNQYLFSTTRVPGVPLDTVRAPYSEQAPGPSTARHIVVFFRGTMFRLDV
IGPDGVPHGLDEIQAGLRAVTKSDVHTAEEDRAGHLTTMARAEWAATRASLVEDRPANAR
TLDDIETALFCVCLEDFAPRDIQAACDELLHGDRGNRWFDKAVSFVVFADGRAGINVEHC
ELDGTTVLSFTDALLGTPPDEHSRASGARPQGVPVPRPLTFELDAAQRARVRSAAEAFAA
YGNDTATRTVSFGDFGSRAAKALGVSPDAFVQSAYQLAHQRAKGHLGATYESIATRQYRY
GRTEAMRVVTPEMQAFVAAMDDPGAGRDTRRAAFRAAAAAHVARAKECQAGEAPEQHLWE
LELIQRRRGEELGVTGQPALYRSPGWLTMRDDYLSTSSAPSENIQYFGFGSTSSKCIGVA
YVLLPDRFNLYLSTPLAVADQMHAFAEHLREAVGELRELLTD
>A0A0H5CMG8 Carnitine O-palmitoyltransferase II, mitochondrial (EC 2.3.1.21)
MNSSPDWSPRTFGNEDRLPRVPLPTLAETCARFLEWCGPLLTAEELAATESAVAAYMAPD
SAAHELHAALVEYNETPGVHSWLDTFWPSRYLGRRDRIALNANFFFLFKDTDETQTERAA
GLIAGAVAYKQLLDDERVPPVVQRGQALSMEQNKYLFSSTRIPGDPQDTVRTPYSDEWPG
PSRARHIAVLRGGNIYRMDVLGAEGTPHSLDDLSAGLNAIIKSAAAPAEFPVGHLTTLAR
AEWAATRQSLAESNAAAVDTIETALFCVCLEDIAPSGDQEACDQLLYGDNRWFDKAVSLV
VFADGKAGINIEHQGLDGTTILAFVDALLNSTPQEHETSSGAAAQGLPAIEPVEFALTDA
LRETIKSAGAAFTQYAADTATQTVSFADFGATRAKQLGMSPDAFAQLAYQLAHKRTKGFA
GATYESIATRQYNRGRTEAMRVVTPEVLAFLSAMESDDVNARRAAFRAAAEKHVARAKEC
QAGQAPEQHLWELQLIQKRRGTGAPLALYDTPGWLKMRDDYLSTSSAPSTNITYFGFGST
SPQCIGVAYVLLPDSLNIYLSTPIQVAAEMHTFADNLSGAVVELQELLA
>W7IT57 Carnitine O-palmitoyltransferase II, mitochondrial (EC 2.3.1.21)
MNSSQQWSTRTFGNEDRLPRVPLPTLEDTCARFLTWCSPLLTPEQLATTEAAVTDYLAAD
SPARVLHADLERFNDAPGTRSWLDVFWPSRYLGRRDRIALNANFFFLFRDTDEDQFQRAA
GLITAAVDFKLLLDKEEVPPVIQRGQALSMEQNKFLFSETRIPGAEQDTVRVPYTDEWPG
PSAARHVVVFNRGSMFRMDVIGPDGAPYSLSDLEGGLRAVVKAGADGTAPDRTVGSLTTQ
ARAEWARTRGRLIALDPANAAAVDTIETALFCVNLESFAPADTQAACDQLLHGDSGNRYF
DKAVSLIVFADGRAGINIEHCGLDGTTILSFVDAMLGETAEAHAERAGARPQGLPAVDPI
EFVLDDALRADIATARRAFAEYAAATATRTVSFTDFGTARAKALKMSPDAFAQLAYQLAH
KRSKGITGATYESIATRQYQNGRTEAMRVVTPEVLAFVEAMGDPAVSAADKRAAFRTAAE
AHVARAKQCQNGQAPEQHLWELQLIQKRRGAELGATAPLALYDTPGWTVMRDDYLSTSSA
PSTNIQYFGFGSTSPTCIGVAYVLLPDRFNLYLSTPAAVAEEMNTFVTELRGAVTELQDL
LASE
>A0A1Q8LAS2 Carnitine O-palmitoyltransferase II, mitochondrial (EC 2.3.1.21)
MGVTTTFAADDDLPKVPLPTLSASAERFLEWCAPLLTPDEYARTETAAHELLVEGGPASV
LQADLERFDAGAHSWLDAFWPSRYLGRRDRIALNANFFFLFGPGTTTDPCERAAQLTVAA
LGHKADLDAGTFPPLVNRGVAQSMDQSRHIFSTTRIPGDPQDTVRTPYSDDWPGPSTERH
VVVLHRGRIHRLDVIGENGAAHTAGEIADALREIREAHPERAATGDAVGALTTLARAEWA
AVRDRLTGLDPANAEAVDLVERALLAVCLDETDPADEESAARTLLAGDSGDRWFDKALSI
VVLADGTAGVNIEHCELDGTTVLTLVDAMFADPVEVHAERIGTRPQGTAPHGELRFVLDD
DLRATVSRAHDEFAAFLDATATELVAFDDFGADDAKALKCSPDAFVQACYQVAHRRAKGV
TGATYESIATRQFRRGRTEAMRVVTPEMVAFVDTMGDPQASDADKVETFRAAAAAHGARA
KQCQQGDAPEQHLWELDWIRRRRGAELGVTEQLAVFDSPGWTIMRDDWLSTSSAPSDNIR
YFGFGSTSSRCIGVAYVLLPDRFHVHLSTPADQAEGMHAFARELRAAVTELRNLLA
>A0A1Q8LYW5 Carnitine O-palmitoyltransferase II, mitochondrial (EC 2.3.1.21)
MGVTTTFAADDDLPKVPLPTLSASAERFLEWCAPLLTPDEYARTETAAHELLVEGGPASV
LQADLERFDAGAHSWLDAFWPSRYLGRRDRIALNANFFFLFGPGTTTDPCERAAQLTVAA
LGHKADLDAGTFPPLVNRGVAQSMDQSRHIFSTTRIPGDPQDTVRTPYSDDWPGPSTERH
VVVLHRGRIHRLDVIGENGAAHTAGEIADALREIREAHPERAATGDAVGALTTLARAEWA
AVRDRLTGLDPANAEAVDLVERALLAVCLDETDPADEESAARTLLAGDSGDRWFDKALSI
VVLADGTAGVNIEHCELDGTTVLTLVDAMFADPVEVHAERIGTRPQGTAPHGELRFVLDD
DLRATVSRAHDEFAAFLDATATELVAFDDFGADDAKALKCSPDAFVQACYQVAHRRAKGV
TGATYESIATRQFRRGRTEAMRVVTPEMVAFVDTMGDPQASDADKVETFRAAAAAHGARA
KQCQQGDAPEQHLWELDWIRRRRGAELGVTEQLAVFDSPGWTIMRDDWLSTSSAPSDNIR
YFGFGSTSSRCIGVAYVLLPDRFHVHLSTPADQAEGMHAFARELRAAVTELRNLLA
>A0A1Q8KX33 Carnitine O-palmitoyltransferase II, mitochondrial (EC 2.3.1.21)
MAVTQPTTFAADDDLPKVPLPTLAASVDRFLEWCAPLLTPDEYARTEAAARELLVPGGTA
EVLQADLERFDASAHSWLDEFWPSRYLGRRDRIALNANFFFQFGPGSADPCERAAELATA
AIGHKADLDAGTFPPLTARGVPQSMDQSRHVFSTTRIPGDPQDTVRSPHTDAWPGPSAER
HVVVFSRGRIHRLDVFGPGGDLHTVPEIADGLRAIRDAYPGRAGLDEAVGSLTTLARAEW
AGVRDRLAGLDPANAEAVDLVERALFAICLDDDVPADDTAAARTLLAGDSGNRWFDKALS
VVVLADGTAGVNIEHCELDGTTVLTLVDAMFADPVETHAARAGAREQGPPAHSELTFVLD
DDLRATVRRAHDDFAAFLGATATTLVAFDDFGAQDAKALKSSPDAFVQAAYQVAHRRAKG
VTGATYESIATRQFRRGRTEAMRVITPEMVAFVDAMQDPQAAGDDRRAAFRLAAEAHGAR
AKQCQQGDAPEQHLWELEWIQRRRGAELAATDPMEVFASPGWTIMRDDWLSTSSAPSENV
RFFGFGSTSSRCIGVAYVLLPDRFHVHLSTPADQADGMQAFARELRVAVGELRNLLA
>A0A1R3UTN0 Carnitine O-palmitoyltransferase II, mitochondrial (EC 2.3.1.21)
MTDPHRPGTFAHDDGLPRLPLPALRDSAQRFLRWCEPLLDNAQFTATETAVAEFLRPKSP
AWALQSELERVDASEDSQSWLDDFWPSQYLGARGRVALDVNYFFLLDDREGDQCERAADL
LAAAVDFKRRVDTEEVPPEAPRGRPQSMEQLKRLFGTTRIPGETMDTVRTPYSPEHPGPS
RARHVVVFSRGHMFAFDVIDPDGRPYTPDELTAGLRALLAAVPERAAPGRSVGHLTTKDR
TEWARSRRALIEIDPANPAALDTVETALLCLSLEGDTPADDRAAAERVLHGDSANRWFDK
ALSFIVFPDGRAGLNCEHSTLDGTTAASFLNAVDGSSTPARIGRDTDRVPGFAPVEFVLD
EALRTDIRESGAAFSDYAAQGVNATFSSREFNSDRAKTLGVSPDAFIQLAFQLAHRRAKG
HLGATYESISSRQYHYGRTETMRVLTPESVAFVEAMEDPGTDVDTRETAARAAAREHSAR
AKGCQVGEGPERHLWTLELIRRDRGASVGAESPMALYNSPGWRIMRSDHLSTSSVPCRPV
RLWGFGSTGPDCIGIGYILLPERIDLHLHAPRSLAEVQERFVQELAGAFEELTELLADTS
TMSTVRG
>A0A1Q8JR27 Carnitine O-palmitoyltransferase II, mitochondrial (EC 2.3.1.21)
MTQPTTFAADDDLPKVPLPTLAASVDRFLEWCAPLLTPDEYARTEAAARELLVPGGTAEV
LQADLERFDASAHSWLDEFWPSRYLGRRDRIALNANFFFQFGPGSADPCERAAELATAAI
GHKADLDAGTFPPLTARGVPQSMDQSRHVFSTTRIPGDPQDTVRSPHTDAWPGPSAERHV
VVFSRGRIHRLDVFGPGGDLHTVPEIADGLRAIRDSYPGRAGLDEAVGSLTTLARPEWAG
VRDRLAGLDPANAEAVDLVERALFAICLDDDVPADDTAAARTLLAGDSGNRWFDKALSVV
VLADGTAGVNIEHCELDGTTVLTLVNAMFADPVETHAARAGAREQGPPAHSELTFVLDDD
LRATVRRAHDDFAAFLGATATTLVAFDDFGAQDAKALKCSPDAFVQAAYQVAHRRAKGVT
GATYESIATRQFRRGRTEAMRVITPEMVAFVDAMQDPQASGDDRRAAFRLAAEAHGARAK
QCQQGDAPEQHLWELEWIQRRRGAELGATGPMEVFASPGWTIMRDDWLSTSSTPSENVRF
FGFGSTSSRCIGVAYVLLPDRFHVHLSTPADQADGMHAFARELRVAVGELRNLLA
>A0A0K3BDM5 Carnitine O-palmitoyltransferase II, mitochondrial (EC 2.3.1.21) (EC 2.3.1.21)
MNDTFSNEDQLPRVPLPTLRDSCALFLEWCAPLLTAAELAETEAAVAEFLAPDSPAHILH
DDLARYDASPGVRSWLDDFWRTRYLGRRDRIALNANFFFLFKDSVGSGQADRAAGLIASA
VAYKAMVDSEQLPPVVLRGQAQSMEQHKYLFSCTRVPGAEQDTARAPYGDEWPGPSPARH
IVVFHRGRMFRMDVLDEQGLPYAISELADGLGAVLASEESQSTSVGHLTTKARAEWAASR
QALIALDPANSEALDVVETALFCVSLEDFAPADKLSACDALLHGDSANRWFDKAVSFVVF
ADGRAGINVEHCLLDGTTILAFVDAVLTTQGTSSEPGKGTPKVESIRFVLDDALHADVTA
AGKAFADYAAANATTDLSFEDMGTSRIKQLGMSPDSFVQAAYQLAHLRSKGLTGATYESI
ATRQYQNGRTEAMRVVTPEMVRFVTAMRDPDTDTATRRAALREAGAKHVARAKQCQAGQA
PEQHLWELQMIQRRRGAELGATAPLRLYESPGWVVMRDDYLSTSSAPSSNIQYFGFGSTS
SRCIGVAYVLLPDRLNIYLSTPQPVADQMYAFADALRGSLQELTDLLATEVSAAQST
>A0A1R4F638 Carnitine O-palmitoyltransferase II, mitochondrial (EC 2.3.1.21)
MSMAPLPVPPLDASLERFLRTVAAIAGPGAEAAARAEVGRFRRGGAQRLQRELERFAESE
HEAGRSWLSEEWSREYLRVREPLPLASNVAYELELAIAAGDPGDEEWAAEAIHRIATVHL
AEARGATSPEVDARGTALSMEQWPRLAGGIRHPRPVEDVFLQAGGASSRPEIGVLRHGRL
FAMPVGDESGRALAIRTIAEQLRRTLALADEGGRGLRAPGFADAAYLGSDALAGPLEGML
SEPENARAYRRAAGLLFVVALTEESADAAERLRALLVEPGRALVRKPLSYQLDLRARRVH
VHSEHSGIDGGTLVEAVRRMQRVHPRAEDDEAPAAPVELRWRWSSGARSALREALEAYRG
RASRIRVELVRAPRIPEERLPFRMSPDALQQLVMTIAQLRAFGRARSAYEAVDMRAFQSG
RTECLRPVTPEAVAFGRALLDGGARPEGLRAALDAHREWVKACKTGHGFDRHFTGLSMIA
ARLGISEPFFACEALAAVRTDLLSTTSLGAAEQIMRYTFAPTTDHGFGIAYTRHPDAFEF
SVSYFEPGSEQPARFLESLSEAARLLNGFIVGLSDSESENPEMTTE
>A0A1C3H7G1 Carnitine O-palmitoyltransferase II, mitochondrial (EC 2.3.1.21)
MKTLPLPSLDDTFATYLQWLRPLVDDKTYAHSAKALEDFRHLEAPKLQRLLEQRADLAAP
DSWLIDYWRGMRLANRGSLPLTGNQAMKIDWKAPQSGLKRVAHFTHALARVHHAYQNGEL
RTILDDPDTCHSQWEVLRGAARRPLPVEDEYTFNSPHDPARHIIILYQGRGWAMDIHDDK
GGIASPAQIENTLYALIQSRPEAPDLPFAAPSVFPNTQAREIRAQLISRGENAAIWQTVE
KALFVLSIDDSHILDDEDALNDAAFSDGSAFWAYKPLNYRCNINDDRYFLHSESTWIDAA
SLADILQLAQNYQRDKQIRRKNTLPENLNLRPLDWQIDKHETKDQDSGTHKLIKDALAEY
RHHAESYTTSIYDLFLNDQEQALLKHNDRDAIMQLALQYAQYKTRKTIKSSRENIDMRHY
QNGRKSYMQSVTATSIATAHAIYQLEDASDIQPLIDQYSKEHRARKHACLNGQDTYGHLL
GLRSIAREQKLEIPFFNDPGYLILTDNHISAITLGHHGILSYIAFTAGGPENIAVNYAFN
RNNINLVLTHPRVRTREIQKFATAIQAGNKQILRILAAQQDE
